Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ho

Showing results (291-300 of 321) with videos related to

Pageof 33
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapyA Schneeweiss, I Diel, M Hensel, et al.
Deutsche Medizinische Wochenschrift (1946)|April 28, 2005
[Integrated skills laboratory concept for undergraduate training in internal medicine]C Nikendei, T Schilling, P Nawroth, et al.
Leukemia|November 20, 2015
Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemiaJ Balss, C Thiede, T Bochtler, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2001
Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapyA Schneeweiss, R Goerner, M A Hensel, et al.
Bone Marrow Transplantation|December 13, 2016
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analysesL Sellner, M Brüggemann, M Schlitt, et al.
Bone Marrow Transplantation|April 6, 2017
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analysesL Sellner, M Brüggemann, M Schlitt, et al.
Annals of Hematology|August 17, 2012
Excellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospitalM Hensel, J Brust, C Plöger, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Pageof 33

Showing results (291-300 of 321) with videos related to

Sort By:
Pageof 33
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapyA Schneeweiss, I Diel, M Hensel, et al.
Deutsche Medizinische Wochenschrift (1946)|April 28, 2005
[Integrated skills laboratory concept for undergraduate training in internal medicine]C Nikendei, T Schilling, P Nawroth, et al.
Leukemia|November 20, 2015
Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemiaJ Balss, C Thiede, T Bochtler, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2001
Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapyA Schneeweiss, R Goerner, M A Hensel, et al.
Bone Marrow Transplantation|December 13, 2016
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analysesL Sellner, M Brüggemann, M Schlitt, et al.
Bone Marrow Transplantation|April 6, 2017
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analysesL Sellner, M Brüggemann, M Schlitt, et al.
Annals of Hematology|August 17, 2012
Excellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospitalM Hensel, J Brust, C Plöger, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Pageof 33